OPTIMIST bridges the knowledge gap
in medical CANNABIS research
OPTILYTICS IS THE DATA COLLECTION AND OUTCOME MEASUREMENT PLATFORM THAT MAKES IT HAPPEN
Traditionally, it takes up to 17 years for medical research to become usable in practice. Our mission is to provide a new approach designed to promptly close the clinical research gap for MMJ. By the end of 2019, Optilytics will put significant, actionable, clinical data into the hands of clinicians and medication formulators who critically need it for improving their practices.
hipaa-compliant, cloud-based data collection is the key
Our partner, Toronto-based software company, Think Research, is helping us deploy the latest technologies in data capture. The results are knowledge-based online tools that, for the first time, empower clinicians to deliver evidence-based MMJ patient care. Leading to better patient outcomes and a new paradigm in MMJ treatment.
Patients provide direct feedback into the Optilytics HIPAA-compliant, cloud-based data collection system. As data accumulates, clear and actionable insights will help clinicians create new and more effective treatment plans. /This dynamic, living database of usable information allows formulators to better meet patient needs and provides a competitive edge for them to gain valuable market share in this emerging market.
nowhere else is data being accumulated so quickly
In the greatest number of states, across the broadest range of ailments and by the largest group of patients and physicians, much needed data is rapidly being collected and aggregated to transform the medical marijuana industry. /Become part of this paradigm shift in MMJ treatment. Contact us to see how.